Abstract:Six new potentially bioactive organotin(IV) complexes were synthesized from the Schiff base ligand derived from phenylhydrazine and 5‐bromo‐2‐hydroxybenzaldehyde. Newly synthesized compounds showed antioxidant activity in the range of 57.68%–74.07%. All of the complexes displayed significant antimicrobial activity. The molecular docking results are consistent with in vitro studies. Six organotin(IV) complexes (1–6) were synthesized, following the general formulas as R2Sn(L)Cl and R3Sn(L), have been reported. In these complexes, L represents a Schiff base prepared by the reaction of phenylhydrazine with 5‐bromo‐2‐hydroxybenzaldehyde, and R = Me, n‐Bu, Ph. Various analytical techniques were employed to characterize and determine the structure of the newly synthesized compounds. The techniques, including the elemental analysis, molar conductivity measurements, UV–visible, FT‐IR, NMR spectroscopy, and mass spectrometry. Spectroscopic analysis suggested that the ligand (4‐bromo‐2‐[(2‐phenylhydrazinylidene)meth‐yl]phenol) (HL) coordinates with the tin (Sn) metal through its phenolic oxygen (O) and azomethine nitrogen (N) atoms. Molar conductivity measurements indicated that all the synthesized compounds are nonelectrolytes. The percent CHN analysis data also corroborates the spectroscopic results. UV–Vis spectra revealed the mode of transitions of electrons due to the π–π* transitions, n–π* transitions, and transitions involving charge transfer from the ligand to the metal, which occurred in recently developed ligand and organotin (IV) complexes. The emergence of additional bands in the FT‐IR spectra of complexes (1–6), attributed to ν(Sn–O) and ν(Sn–N), which were absent in the precursor, offers further proof for the synthesis of these complexes. NMR spectral studies give information about the nature and number of all protons having the same or different chemical environment in the structure of all the compounds being reported in this study. The potential to be used as bioactive compounds in the future was assessed by performing the biological activities (antimicrobial and antioxidant) of these synthesized compounds and the DPPH free radical method for the antioxidant potential of these compounds. Based on these assessments, it can be concluded that the ligand's efficiency improves upon complexation, primarily due to the type and quantity of alkyl groups attached to the [Sn] metal atom. ADME and studies were conducted to forecast the biological effectiveness of the ligand and its metal complexes. Among these, the ligand and complexes 1 and 4 are prioritized for docking with Aspergillus flavus, Bacillus subtilis, and Escherichia coli. The complexes 1 and 4 were found biologically more effective towards different microbes. The Antioxidant activity of the test complexes follows this trend: Methyltin(IV) complexes exhibit the lowest activity, whereas butyltin(IV) and phenyl(IV) complexes exhibit higher levels of activity, with phenyltin(IV) showing the most significant activity.

Synthesis and antiproliferative activity of novel organotin complexes bearing abiraterone drug moiety

Organotin(IV) complexes derived from 2,6-diacetylpyridine bis(2-hydroxybenzoylhydrazone) as prospective anti-proliferative agents: Synthesis, characterization, structures and in vitro anticancer activity

New Tin (IV) and Organotin (IV) Complexes with a Hybrid Thiosemicarbazone/Hydrazone Ligand: Synthesis, Crystal Structure, and Antiproliferative Activity

Synthesis, structural elucidation and anticancer activity of diorganotin(IV) complexes derived from isonicotinoyl hydrazones

Design, synthesis and mechanistic studies of novel arylformylhydrazone butylphenyltin complexes as potential anticancer agents

In Vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell Lines

Diorganotin (IV) amino acid complexes as potential anticancer agents. Synthesis, structural characterization, and in vitro assays

In vitro anticancer, antioxidant, antimicrobial, antileishmanial, enzymes inhibition and in vivo anti-inflammatory activities of organotin(IV) derivatives of 4-bromophenoxyacetic acid

Synthesis, characterization and in vitro antitumor activity of three organotin(IV) complexes with carbazole ligand

Synthesis, Spectral Characterization and Biological Evaluation of Organotin(IV) Complexes of Aniline Derivatives of Naturally Occurring Betulinic Acid

Tin(IV) Complexes With 2‐Formylpyridine Thiosemicarbazones: Structural and Cytotoxic Activity Studies on Bacterial, Fungal, and Cancer Cells

The Development of Organotin(IV) N -Ethyl- N -Benzyldithiocarbamate Complexes: A Study on Their Synthesis, Characterization, and Cytocidal Effects on A549 Cell Line

Formation, Structure and in Vitro Antitumour Activity of a Novel Binuclear Organotin Complex

Comprehensive Investigation of Organotin(IV) Complexes Derived From a Novel Schiff Base: Synthesis, Characterization, Antioxidant, ADME Profiling, and In Vitro Biological Evaluation

New Organotin (IV) Compounds Derived from Dehydroacetic Acid and Thiosemicarbazides: Synthesis, Rational Design, Cytotoxic Evaluation, and Molecular Docking Simulation

Synthesis, Characterization and Biological Activity of Diorganotin(IV) Complexes of N‐(3,5‐Dibromo‐salicylidene)‐ Α‐amino Acid

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis, crystal structure and antitumor activity of trialkyltin (IV) 9,10-anthraquinone-2-carboxylate

Synthesis, Characterization and Antiproliferative Activity Test of Some Diphenyltin(IV) Hydroxybenzoates Against A549, MCF-7 and HeLa Human Cancer Cell Lines

Synthesis, characterization andin vitro antitumour activity of di- and tri-organotin derivatives of fenbufen

Synthesis, characterization, in vitro antioxidant and antimicrobial activities of diorganotin(IV) complexes derived from hydrazide Schiff base ligands